What is Nowatch?
Nowatch operates at the intersection of biometric data and mental health, offering a unique wearable device designed to mitigate burnout through predictive analytics. Unlike traditional fitness trackers, the Nowatch platform focuses on cortisol level monitoring, providing users with actionable insights up to 60 minutes before stress triggers manifest. By integrating sophisticated sensors that track heart rate, temperature, and sleep patterns into a screenless, aesthetic form factor, the company bridges the gap between clinical-grade health monitoring and consumer-facing lifestyle technology. This approach addresses the critical need for preventative mental health tools in an increasingly high-pressure professional landscape.
How much funding has Nowatch raised?
Nowatch has raised a total of $8.7M across 1 funding round:
Series A
$8.7M
Series A (2022): $8.7M with participation from Flow Ventures and Chris Hall
Key Investors in Nowatch
Flow Ventures
Flow Ventures is a specialized consulting firm with deep expertise in maximizing research and development tax credits and supporting high-growth technology ventures.
Chris Hall
An individual investor providing strategic backing to early-stage health technology companies.
What's next for Nowatch?
With the recent influx of capital, Nowatch is poised to transition from its initial market entry phase into a broader enterprise-level scaling strategy. The company's roadmap likely involves enhancing its predictive algorithms and deepening its integration with corporate wellness programs, where the demand for stress-mitigation tools is highest. As the firm continues to refine its proprietary technology, the focus will remain on establishing the Nowatch device as an essential component of holistic health management, potentially exploring partnerships with healthcare providers and insurance entities to validate its efficacy in clinical settings.
See full Nowatch company page
